An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia

NCT04173260 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Dystonia, Primary

Interventions

DRUG: Deutetrabenazine 6 MG

Sponsor

University of Pennsylvania

Collaborators

[object Object]